Drug Giant AstraZeneca Launches Evinova to Quicken Clinical Trials
Evinova aims to use AI to design studies, automate cost calculations, and determine feasibility for drug testing.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
Canary Staked INJ ETF aims to bring regulated Injective staking to Nasdaq
The proposed ETF could enhance US investor access to crypto staking, but regulatory approval and inherent risks may impact its suc...
SEC puts AI claims under the microscope as the spending boom accelerates
Increased SEC scrutiny on AI claims may lead to stricter compliance costs and heightened investor awareness of AI-related risks an...
Franklin Templeton Officially Launches 2 Bitcoin DRIP ETFs That Turn Dividends Into Bitcoin
Bitcoin Magazine Franklin Templeton Officially Launches 2 Bitcoin DRIP ETFs That Turn Dividends Into Bitcoin Two Nasdaq-listed fun...
DTCC Launches Tokenized Securities Service as Wall Street Tests New Settlement Rails
TL;DR: The Depository Trust Company, part of DTCC, launched its tokenization service on October 28, moving a particularly importan...
Phase blockchain launches mainnet with $45M commitment from Unlimit founder Kirill Eves
Phase's launch could democratize blockchain participation, leveraging smartphones for AI tasks, but centralized funding may impact...
Multichain wallet Keeper launches TRUMP token competition offering invitations to Trump gala dinner
The competition could boost Keeper's user engagement and market presence, highlighting the growing intersection of politics and cr...